Cargando…

Constipation in adults with neurofibromatosis type 1

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal-dominant disease characterised by symptoms of the skin, eyes, nervous system and bones. A previous study indicated that constipation, large rectal diameters and prolonged colorectal transit times are common in children with NF1. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ejerskov, Cecilie, Krogh, Klaus, Ostergaard, John R., Fassov, Janne L., Haagerup, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559807/
https://www.ncbi.nlm.nih.gov/pubmed/28814319
http://dx.doi.org/10.1186/s13023-017-0691-4
_version_ 1783257581453574144
author Ejerskov, Cecilie
Krogh, Klaus
Ostergaard, John R.
Fassov, Janne L.
Haagerup, Annette
author_facet Ejerskov, Cecilie
Krogh, Klaus
Ostergaard, John R.
Fassov, Janne L.
Haagerup, Annette
author_sort Ejerskov, Cecilie
collection PubMed
description BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal-dominant disease characterised by symptoms of the skin, eyes, nervous system and bones. A previous study indicated that constipation, large rectal diameters and prolonged colorectal transit times are common in children with NF1. The aim of the present study was to investigate and compare the prevalence of gastrointestinal symptoms in adult patients with NF1 to their unaffected relatives serving as the control group. Patients with NF1 were recruited from one of two Danish National Centres of Expertise for NF1 and their unaffected relatives were invited to participate as controls. Gastrointestinal symptoms were assessed with a web-based, self-administered, validated, Rome® III diagnostic questionnaire. Logistic regression was used to estimate the prevalence of functional dyspepsia, IBS and functional constipation in each group and the groups were compared using their odds ratios. RESULTS: The response rates for patients and controls were 66.4% and 82.4%, respectively. We compared 175 patients, median age 34.2 (IQR = 20.1) and 91 of their unaffected relatives, median age 42.0 (IQR = 12). The overall likelihood of fulfilling the diagnostic criteria for functional constipation, irritable bowel syndrome or functional dyspepsia was 33.1% among patients vs. 14.3% among controls, (odds ratio (OR): 2.97; 95% CI: 1.56–5.66) and after adjustment for age and gender (OR: 3.06; 95% CI: 1.62–5.79). The likelihood of functional constipation was higher among patients (OR: 3.80; 95% CI: 1.27–11.31), and this was still true after adjustment (OR: 3.49; 95% CI: 1.14–10.64). The likelihood of irritable bowel syndrome (OR: 2.29; 95% CI: 0.98–5.33) was evident after adjustment (OR: 2.46; 95% CI: 1.10–5.47), whereas there was no difference in the likelihood of functional dyspepsia (OR: 2.35; 95% CI: 0.67–8.32) after adjustment (OR:2.25; 95% CI: 0.70–7.17). CONCLUSIONS: Overall, having symptoms usually attributed to either functional dyspepsia, IBS or functional constipation is more common in adults with NF1 compared to unaffected relatives. Of the three, the likelihood of constipation is markedly higher. The high prevalence of constipation indicates that it is not functional but part of the NF1 disorder.
format Online
Article
Text
id pubmed-5559807
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55598072017-08-18 Constipation in adults with neurofibromatosis type 1 Ejerskov, Cecilie Krogh, Klaus Ostergaard, John R. Fassov, Janne L. Haagerup, Annette Orphanet J Rare Dis Research BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal-dominant disease characterised by symptoms of the skin, eyes, nervous system and bones. A previous study indicated that constipation, large rectal diameters and prolonged colorectal transit times are common in children with NF1. The aim of the present study was to investigate and compare the prevalence of gastrointestinal symptoms in adult patients with NF1 to their unaffected relatives serving as the control group. Patients with NF1 were recruited from one of two Danish National Centres of Expertise for NF1 and their unaffected relatives were invited to participate as controls. Gastrointestinal symptoms were assessed with a web-based, self-administered, validated, Rome® III diagnostic questionnaire. Logistic regression was used to estimate the prevalence of functional dyspepsia, IBS and functional constipation in each group and the groups were compared using their odds ratios. RESULTS: The response rates for patients and controls were 66.4% and 82.4%, respectively. We compared 175 patients, median age 34.2 (IQR = 20.1) and 91 of their unaffected relatives, median age 42.0 (IQR = 12). The overall likelihood of fulfilling the diagnostic criteria for functional constipation, irritable bowel syndrome or functional dyspepsia was 33.1% among patients vs. 14.3% among controls, (odds ratio (OR): 2.97; 95% CI: 1.56–5.66) and after adjustment for age and gender (OR: 3.06; 95% CI: 1.62–5.79). The likelihood of functional constipation was higher among patients (OR: 3.80; 95% CI: 1.27–11.31), and this was still true after adjustment (OR: 3.49; 95% CI: 1.14–10.64). The likelihood of irritable bowel syndrome (OR: 2.29; 95% CI: 0.98–5.33) was evident after adjustment (OR: 2.46; 95% CI: 1.10–5.47), whereas there was no difference in the likelihood of functional dyspepsia (OR: 2.35; 95% CI: 0.67–8.32) after adjustment (OR:2.25; 95% CI: 0.70–7.17). CONCLUSIONS: Overall, having symptoms usually attributed to either functional dyspepsia, IBS or functional constipation is more common in adults with NF1 compared to unaffected relatives. Of the three, the likelihood of constipation is markedly higher. The high prevalence of constipation indicates that it is not functional but part of the NF1 disorder. BioMed Central 2017-08-16 /pmc/articles/PMC5559807/ /pubmed/28814319 http://dx.doi.org/10.1186/s13023-017-0691-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ejerskov, Cecilie
Krogh, Klaus
Ostergaard, John R.
Fassov, Janne L.
Haagerup, Annette
Constipation in adults with neurofibromatosis type 1
title Constipation in adults with neurofibromatosis type 1
title_full Constipation in adults with neurofibromatosis type 1
title_fullStr Constipation in adults with neurofibromatosis type 1
title_full_unstemmed Constipation in adults with neurofibromatosis type 1
title_short Constipation in adults with neurofibromatosis type 1
title_sort constipation in adults with neurofibromatosis type 1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559807/
https://www.ncbi.nlm.nih.gov/pubmed/28814319
http://dx.doi.org/10.1186/s13023-017-0691-4
work_keys_str_mv AT ejerskovcecilie constipationinadultswithneurofibromatosistype1
AT kroghklaus constipationinadultswithneurofibromatosistype1
AT ostergaardjohnr constipationinadultswithneurofibromatosistype1
AT fassovjannel constipationinadultswithneurofibromatosistype1
AT haagerupannette constipationinadultswithneurofibromatosistype1